Plasma β amyloid and impaired CO2-induced cerebral vasomotor reactivity

Neurobiology of Aging

Volumn 28, Issue 5, 2007, Pages 707-712

  van Dijk, Ewoud J ^a   Prins, Niels D ^a   Hofman, Albert ^a   van Duijn, Cornelia M ^a   Koudstaal, Peter J ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid ; Cerebral autoregulation; Cerebral small vessel disease; Epidemiology; Transcranial doppler

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CARBON DIOXIDE;

ADULT; AGED; ARTICLE; BRAIN; CONFIDENCE INTERVAL; DOPPLER FLOWMETRY; FEMALE; HUMAN; HYPERCAPNIA; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MALE; MISCELLANEOUS NAMED GROUPS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; SEX; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; VASOMOTOR REFLEX;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; BRAIN; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOMOTOR SYSTEM;

EID: 33847372484     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.03.011     Document Type: Article

References (28)

1. Bakker S.L., de Leeuw F.E., de Groot J.C., Hofman A., Koudstaal P.J., and Breteler M.M. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 52 (1999) 578-583
2. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17 (1997) 263-264
3. Bass A., Krupski W.C., Schneider P.A., Otis S.M., Dilley R.B., and Bernstein E.F. Intraoperative transcranial Doppler: limitations of the method. J Vasc Surg 10 (1989) 549-553
4. Bots M.L., van Swieten J.C., Breteler M.M., de Jong P.T., van Gijn J., Hofman A., et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 341 (1993) 1232-1237
5. Crawford F., Suo Z., Fang C., and Mullan M. Characteristics of the in vitro vasoactivity of beta-amyloid peptides. Exp Neurol 150 (1998) 159-168
6. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., and Holtzman D.M. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295 (2002) 2264-2267
7. DeMattos R.B., Bales K.R., Parsadanian M., O'Dell M.A., Foss E.M., Paul S.M., et al. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J Neurochem 81 (2002) 229-236
8. Dumville J., Panerai R.B., Lennard N.S., Naylor A.R., and Evans D.H. Can cerebrovascular reactivity be assessed without measuring blood pressure in patients with carotid artery disease?. Stroke 29 (1998) 968-974
9. Gray F., Dubas F., Roullet E., and Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 18 (1985) 54-59
10. Greenberg S.M., Rebeck G.W., Vonsattel J.P., Gomez-Isla T., and Hyman B.T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38 (1995) 254-259
11. 2 reactivity testing without blood pressure monitoring?. Stroke 30 (1999) 398-401
12. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7 (1991) 403-422
13. Holtzman D.M., Fagan A.M., Mackey B., Tenkova T., Sartorius L., Paul S.M., et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol 47 (2000) 739-747
14. Jensen M., Schroder J., Blomberg M., Engvall B., Pantel J., Ida N., et al. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol 45 (1999) 504-511
15. Mehta P.D., Pirttila T., Patrick B.A., Barshatzky M., and Mehta S.P. Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304 (2001) 102-106
16. Niwa K., Kazama K., Younkin L., Younkin S.G., Carlson G.A., and Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283 (2002) H315-H323
17. Paulson O.B., Strandgaard S., and Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2 (1990) 161-192
18. 2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke 19 (1988) 963-969
19. Ruitenberg A., den Heijer T., Bakker S.L., van Swieten J.C., Koudstaal P.J., Hofman A., et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57 (2005) 789-794
20. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2 (1996) 864-870
21. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
22. Thomas T., Thomas G., McLendon C., Sutton T., and Mullan M. Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380 (1996) 168-171
23. Tokuda T., Fukushima T., Ikeda S., Sekijima Y., Shoji S., Yanagisawa N., et al. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome. Ann Neurol 41 (1997) 271-273
24. van Dijk E.J., Prins N.D., Vermeer S.E., Hofman A., van Duijn C.M., Koudstaal P.J., et al. Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions. Ann Neurol 55 (2004) 570-575
25. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke 18 (1987) 311-324
26. Weller R.O., Massey A., Newman T.A., Hutchings M., Kuo Y.M., and Roher A.E. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 153 (1998) 725-733
27. Wenham P.R., Price W.H., Blandell G., and Apolipoprotein. E genotyping by one-stage PCR. Lancet 337 (1991) 1158-1159
28. Yamauchi H., Fukuyama H., Nagahama Y., Shiozaki T., Nishizawa S., Konishi J., et al. Brain arteriolosclerosis and hemodynamic disturbance may induce leukoaraiosis. Neurology 53 (1999) 1833-1838